U.S. Pharma Stock News

VSE (VSEC) has just reported quarterly results that came in ahead of analyst expectations, with higher operating margins, record aviation revenue, and a 2026 growth outlook that factors in recent acquisitions. See our latest analysis for VSE. Those results come after a strong run in the shares, with the latest price at $227.07, a 90 day share price return of 30.31% and a 1 year total shareholder return of 92.15%. This points to strengthening momentum as investors reassess growth prospects and...

In February 2026, Trinity Capital Inc. reported its fourth-quarter and full-year 2025 results, with revenue rising to US$83.24 million for the quarter and US$293.65 million for the year, alongside higher annual net income but lower earnings per share versus 2024. The company paired these record operating figures with a shift to monthly dividends, an intensified focus on AI infrastructure financing, and a US$50 million growth capital commitment to UK-based Dwelly, signaling an emphasis on...

Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its drug diversion detection capabilities and recurring revenue base. This pivot toward subscription-like revenue streams is prompting investors to reassess Omnicell less as a traditional equipment maker and more as a healthcare IT provider, with different expectations for growth, risk and valuation. Next, we’ll examine how Omnicell’s...

In Q4 2025, Harbor Capital Advisors' Mid Cap Value Fund disclosed that it had initiated a new position in EnerSys, citing improving operating margins, sales growth, strong cash flow, ongoing share buybacks, and regular dividend payments as key reasons for the investment. The fund also ranked EnerSys in the top 5% of its evaluation universe, highlighting how the company’s combination of operating momentum and capital returns screens well against a broad mid-cap peer group. Next, we’ll examine...

Arcus Biosciences stock: event driven overview Arcus Biosciences (RCUS) has caught investor attention after recent trading action, with the stock now sitting around $20.37. That move comes against a mixed return profile across the past month and past 3 months. See our latest analysis for Arcus Biosciences. The latest move puts Arcus Biosciences at US$20.37, with the 1 day share price return of 4.25% and 7 day share price return of 7.27% sitting against a weaker 90 day share price return of a...

Recent commentary around MGM Resorts International (MGM) has focused on its aggressive share repurchases, the expanding BetMGM digital gaming footprint, and a series of catalysts that include asset sales, the Las Vegas recovery, and the planned Osaka integrated resort. See our latest analysis for MGM Resorts International. At a share price of $36.86, MGM’s recent 30 day share price return of 9.90% contrasts with a 1 year total shareholder return of 6.04% and a 3 year total shareholder loss of...

Valley National Bancorp (VLY) shares dropped 6.2% as hotter inflation data and growing credit risk worries pressured regional lenders, even though the bank confirmed regular dividends and a new share repurchase authorization. See our latest analysis for Valley National Bancorp. Despite the latest 5.7% one day share price decline to US$12.61, Valley National Bancorp’s 90 day share price return of 9.8% and 1 year total shareholder return of 34.0% suggest momentum has generally been positive...

Arcosa (ACA) is back on investors’ radar after a recent share pullback over the past week and month, drawing attention to how its infrastructure focused business and current valuation metrics stack up today. See our latest analysis for Arcosa. The sharp 1 day share price decline of 15.7% and 7 day share price return of 14.9% sit against a 1 year total shareholder return of 28.42% and 5 year total shareholder return of 84.39%. This suggests recent momentum has cooled after a strong multi year...

Why Marriott Vacations Worldwide (VAC) Is Drawing Fresh Attention Marriott Vacations Worldwide (VAC) has been catching investors’ eyes after recent share moves, with the stock showing a mix of shorter term gains and longer term weakness that raises questions about valuation and business momentum. See our latest analysis for Marriott Vacations Worldwide. The recent 7 day share price return of 10.37% and 30 day share price return of 19.70% contrast with a 1 year total shareholder return decline...

Franklin Resources recently reported quarterly earnings per share that came in above analyst consensus, while Franklin Templeton Canada adjusted risk ratings on selected funds following an Ontario Securities Commission review that did not alter their mandates or management. Alongside this earnings surprise, Franklin Resources is highlighting its presence at the THRIVE Energy Conference in Houston, where portfolio manager Fred Fromm is presenting, underscoring the firm’s efforts to engage...

In February 2026, Ladder Capital Corp. announced it had secured US$675 million in new unsecured capital commitments, expanding its unsecured revolving credit facility to US$1.25 billion and adding a US$275 million unsecured delayed draw term loan priced at 140 basis points over SOFR. This package of same-day liquidity at 125 basis points over SOFR and long-dated funding to 2030 materially strengthens Ladder’s funding flexibility and duration profile. Next, we’ll examine how this expanded...

Sable Offshore Corp. reported a full-year net loss of US$410.16 million for 2025, an improvement from the prior year’s US$629.07 million loss, alongside the restart of production at its Santa Ynez Unit after completing pipeline repairs and hydrotests. The company also secured key regulatory support, including PHMSA oversight and an emergency special permit, and advanced its offshore storage and treating vessel strategy to access both domestic and global petroleum markets. We’ll now look at...

In its latest quarterly update, First Financial Bancorp reported revenue up 12.1% year on year, alongside beats on analysts’ revenue, tangible book value per share, and earnings per share estimates. This outperformance came despite the bank’s historically modest revenue and net interest income growth, highlighting a recent improvement relative to earlier trends. With these earnings and tangible book value surprises now on the table, we’ll examine how they reshape First Financial Bancorp’s...

Horace Mann Educators (HMN) has launched the Horace Mann Club, a complimentary program that broadens its educator support through professional development, fitness and wellness partnerships, financial wellness tools, and classroom resources. See our latest analysis for Horace Mann Educators. At a share price of $43.51, Horace Mann Educators has seen a 7 day share price return of 0.90%, alongside a year to date share price decline of 3.70%. Its 1 year total shareholder return of 6.10% and 3...

Primerica (PRI) has been back in focus after its latest 10-K highlighted growth tied to commissions, fees, and net premiums, along with higher dividends, ongoing share repurchases, and reaffirmed strong credit ratings from AM Best. See our latest analysis for Primerica. Despite stronger financial disclosures and affirmed credit ratings, Primerica’s recent share price momentum has cooled, with a 30-day share price return of a 3.57% decline and a 1-year total shareholder return of an 11.09%...

Fourth quarter earnings and capital returns in focus OneSpaWorld Holdings (OSW) reported its fourth quarter and full year 2025 results, with higher revenue and slightly lower net income, alongside fresh revenue guidance, a quarterly dividend, increased impairments and a completed share buyback tranche. See our latest analysis for OneSpaWorld Holdings. The earnings release, dividend affirmation and completed share buyback came after a choppy period for the share price, with a 1 month share...

In February 2026, Interparfums, Inc. reported record 2025 sales of US$1.49 billion and higher earnings per share, while its board kept the annual dividend at US$3.20 per share and reaffirmed 2026 guidance of US$1.48 billion in sales and EPS of US$4.85. Beyond the headline growth, the year was shaped by successful new fragrance launches, fresh long-term licenses, and broader global distribution that helped support performance despite tariff and currency pressures. We’ll now explore how this...

BETA Technologies (BETA) has drawn fresh attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months while the business continues to report rapid annual revenue growth. See our latest analysis for BETA Technologies. The latest pullback has extended BETA Technologies' year to date share price return to a 31.21% decline, with the 90 day share price return of 31.06% pointing to fading momentum despite a flat 7 day move and recent revenue...

In late February 2026, United Therapeutics announced TreSMI, a new generation of inhaled treprostinil intended to reduce coughing, while Liquidia continued to await a court decision on the critical ’327 patent litigation that could shape its competitive footing in pulmonary hypertension. The combination of a potential rival inhaled treprostinil product and unresolved patent risk introduces fresh uncertainty around how Liquidia’s PRINT-enabled franchise might compete and grow within a...

In February 2026, Sanofi and Teva Pharmaceutical Industries reported that duvakitug, an investigational TL1A-targeting antibody, achieved durable 44-week clinical and endoscopic efficacy with consistent safety in ulcerative colitis and Crohn’s disease responders in the RELIEVE UCCD long-term extension study. A separate recent milestone saw the US FDA accept Teva’s New Drug Application for TEV-749, a once-monthly olanzapine injection for adult schizophrenia, underscoring the company’s push...

First Financial Bankshares recently filed its 2025 10-K, detailing its financial results, risk management profile, and an extension of its stock repurchase authorization allowing the company to buy back up to 5,000,000 common shares through July 31, 2026. The filing also underscores a continued focus on organic expansion in non-metropolitan Texas markets and potential acquisitions of high-quality banks, supported by strong regulatory capital ratios and a consistent dividend policy. Next,...

Event context and recent share performance National Vision Holdings (EYE) has drawn investor attention recently as its share price moved to a last close of $26.97, with returns of about 2.4% over the past month and a 3.6% decline over the past 3 months. See our latest analysis for National Vision Holdings. Looking beyond the past month, the 1 year total shareholder return of 112.2% contrasts with a modest 3.93% year to date share price return. This suggests momentum has cooled after a strong...

In late February 2026, Clarivate Plc reported fourth-quarter 2025 sales of US$617 million, full-year 2025 sales of US$2.46 billion, and a quarterly net income of US$3.1 million compared with a net loss a year earlier, alongside sharply lower goodwill and intangible asset impairments of US$15.0 million. The company also issued 2026 guidance pointing to ongoing net losses of US$124 million to US$189 million on revenues of US$2.30 billion to US$2.42 billion, highlighting that profitability...

FedEx has filed a lawsuit against the US government seeking reimbursement of tariffs that were ruled invalid by the Supreme Court. The company has pledged to return any recovered tariff funds to affected shippers and consumers. The move has triggered class-action lawsuits from customers and drawn political scrutiny over how potential multibillion dollar tariff refunds will be handled. For investors watching NYSE:FDX, this legal push comes at a time when the stock trades around $387.0 and...